Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2025-02-11 Earnings Release
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Earnings Release 2024
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké 2024" (Year-End Report/Closing Statement 2024) and contains detailed financial figures for the fourth quarter (oktober-december 2024) and the full year (januari-december 2024). It includes key performance indicators (KPIs), income statement details (Nettoomsättning, Bruttoresultat, Rörelseresultat, Periodens resultat), cash flow information, and a CEO's commentary. This structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR), but since it covers the full year ('Bokslutskommuniké' often implies the final results announcement) and provides comprehensive financial breakdowns, it aligns best with an Earnings Release (ER) which announces the period's results, or potentially an Interim Report (IR) if it were a half-year report. Given the comprehensive nature covering the full year and the immediate release of key figures, it functions as the primary announcement of the annual results, fitting the 'Earnings Release' definition (ER) which covers periodical financial results announcements. It is not a full 10-K, nor is it just a short announcement of a report (RPA/RNS). Q4 2024
2025-02-11 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by Keel Capital AB in Boule Diagnostic AB, specifically noting a sale that reduced their ownership below the 5% threshold. This is a standard regulatory disclosure for major shareholding notifications.
2024-10-30 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport Q3 2024' (Interim Report Q3 2024) and contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance for the third quarter of 2024. It provides detailed financial data rather than just a summary or announcement, fitting the definition of an Interim/Quarterly Report (IR). Q3 2024
2024-10-25 Swedish
Boule Diagnostics rapporterar engångskostnader i tredje kvartalet
Regulatory Filings Classification · 1% confidence The document is a press release from Boule Diagnostics announcing significant one-time impairment charges (write-downs) related to a development project and Russian assets ahead of their full quarterly report. It is a short, standalone announcement (under 5,000 characters) that provides key financial highlights and management commentary regarding specific business developments. It does not constitute a full quarterly report (IR) or an earnings release (ER) in the traditional sense of reporting full financial results, but rather a specific regulatory disclosure of material financial impact. Given the nature of the announcement regarding financial adjustments, it fits best as a Regulatory Filing (RNS).
2024-10-08 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport Q2 2024' (Interim Report Q2 2024) and contains comprehensive financial statements, key performance indicators (KPIs), management commentary, and detailed breakdowns of revenue, costs, and cash flow for the second quarter of 2024. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q2 2024
2024-07-22 Swedish
Kommuniké från Boule Diagnostics årsstämma den 8 maj 2024
AGM Information Classification · 1% confidence The document is explicitly titled "Kommuniké från Boule Diagnostics årsstämma den 8 maj 2024" (Communication from Boule Diagnostics Annual General Meeting on May 8, 2024). It details the resolutions passed at the AGM, such as approving financial statements, deciding on profit distribution, electing board members, and approving remuneration policies. This content directly corresponds to the definition of AGM Information.
2024-05-08 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.